The US FDA on Wednesday approved Revolution Medicines’ Rasonque for advanced pancreatic cancer, opening a new treatment option for patients with metastatic disease. A large trial found the once-daily pill doubled survival rates, offering fresh hope for people who have exhausted other treatments.
Trending
- Unexpected chat between OpenAI bots led to Hugging Face hack
- Ancient SHARK graveyard found in Egypt desert as scientists hail ‘extraordinary’ discovery with seven different species
- Zelfs 3 weken gezonder leven helpt: minder complicaties na operatie voor vrouwen met gynaecologische kanker
- Reading and Leeds Festival: Your guide to toxin-free make-up
- OpenAI says it detected malign activity months before Hugging Face attack | Technology
- Dark Clouds for the Economy: Trump's Attacks on the Fed Could Signal a MAGA Takeover
- Rupert Grint to reprise Ron Weasley role in Harry Potter and the Cursed Child on Broadway
- FDA approves new drug Rasonque to treat advanced pancreatic cancer
